![Peter McNamara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter McNamara
No open positions remaining
Net worth: 2 M $ as of 30/06/2026
Profile
Dr. Peter McNamara is a Chief Scientific Officer at Tectonic Therapeutic, Inc. Dr. McNamara was previously employed as a Chief Scientific Officer by AVROBIO, Inc., an Executive Director-Biotherapeutics & Biotechnology by Novartis Institute for Functional Genomics, Inc., and a Director-Pharmacology by Phenomix Corp.
He received his undergraduate degree from National University of Ireland Galway and a doctorate degree from National University of Ireland Galway.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.29% | 30/06/2026 | 55,285 ( 0.29% ) | 2 M $ | 30/06/2026 |
Peter McNamara active positions
| Companies | Position | Start |
|---|
Former positions of Peter McNamara
| Companies | Position | End |
|---|---|---|
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Corporate Officer/Principal | 01/04/2021 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Corporate Officer/Principal | 01/08/2005 |
| TECTONIC THERAPEUTIC, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Peter McNamara
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
National University of Ireland Galway
 National University of Ireland Galway Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Peter McNamara
